CAR T-cell Therapy Market Trends: Technological Advances Set to Drive 32.5% CAGR Growth
CAR T-cell therapy has emerged as a groundbreaking advancement in cancer treatment, transforming patient outcomes and presenting a promising alternative to traditional therapies. As of 2023, the CAR T-cell therapy market was valued at USD 4.4 billion and is projected to surpass USD 31.2 billion by 2030, growing at a remarkable CAGR of 32.5% from 2024 to 2030. This rapid expansion...
0 Yorumlar
0 hisse senetleri